Central Asia: Market for Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses 2022

Exports of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses

Exports in Central Asia

In 2021, exports of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses in Central Asia skyrocketed to X tons, surging by X% against the previous year. In general, exports continue to indicate a significant increase. As a result, the exports attained the peak and are likely to continue growth in the immediate term.

In value terms, human and animal blood exports surged to $X in 2021. Overall, exports recorded prominent growth. As a result, the exports attained the peak and are likely to continue growth in the immediate term.

Exports by Country

Uzbekistan represented the key exporter of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses in Central Asia, with the volume of exports reaching X tons, which was approx. X% of total exports in 2021. It was distantly followed by Kazakhstan (X tons), comprising a X% share of total exports.

Uzbekistan was also the fastest-growing in terms of the human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses exports, with a CAGR of +X% from 2012 to 2021. At the same time, Kazakhstan (+X%) displayed positive paces of growth. While the share of Uzbekistan (+X p.p.) increased significantly in terms of the total exports from 2012-2021, the share of Kazakhstan (-X p.p.) displayed negative dynamics.

In value terms, Kazakhstan ($X) remains the largest human and animal blood supplier in Central Asia, comprising X% of total exports. The second position in the ranking was held by Uzbekistan ($X), with a X% share of total exports.

In Kazakhstan, human and animal blood exports decreased by an average annual rate of -X% over the period from 2012-2021.

Export Prices by Country

In 2021, the export price in Central Asia amounted to $X per ton, increasing by X% against the previous year. Overall, the export price, however, continues to indicate a abrupt setback. The growth pace was the most rapid in 2015 when the export price increased by X%. As a result, the export price attained the peak level of $X per ton. From 2016 to 2021, the the export prices remained at a somewhat lower figure.

Prices varied noticeably by the country of origin: the country with the highest price was Kazakhstan ($X per ton), while Uzbekistan amounted to $X per ton.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by Kazakhstan (-X%).

Imports of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses

Imports in Central Asia

In 2021, imports of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses in Central Asia declined markedly to X tons, with a decrease of -X% against the previous year's figure. Over the period under review, imports, however, recorded a strong expansion. The growth pace was the most rapid in 2013 with an increase of X%. The volume of import peaked at X tons in 2020, and then dropped significantly in the following year.

In value terms, human and animal blood imports shrank to $X in 2021. Overall, imports, however, continue to indicate a strong expansion. The pace of growth was the most pronounced in 2013 with an increase of X%. As a result, imports reached the peak of $X. From 2014 to 2021, the growth of imports failed to regain momentum.

Imports by Country

In 2021, Kazakhstan (X tons) was the main importer of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses, achieving X% of total imports. Uzbekistan (X tons) took a X% share (based on physical terms) of total imports, which put it in second place, followed by Kyrgyzstan (X%). Tajikistan (X tons), Mongolia (X tons) and Turkmenistan (X tons) took a minor share of total imports.

Imports into Kazakhstan increased at an average annual rate of +X% from 2012 to 2021. At the same time, Tajikistan (+X%), Uzbekistan (+X%) and Mongolia (+X%) displayed positive paces of growth. Moreover, Tajikistan emerged as the fastest-growing importer imported in Central Asia, with a CAGR of +X% from 2012-2021. Kyrgyzstan experienced a relatively flat trend pattern. By contrast, Turkmenistan (-X%) illustrated a downward trend over the same period. While the share of Uzbekistan (+X p.p.), Kazakhstan (+X p.p.) and Tajikistan (+X p.p.) increased significantly in terms of the total imports from 2012-2021, the share of Turkmenistan (-X p.p.) and Kyrgyzstan (-X p.p.) displayed negative dynamics. The shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, Uzbekistan ($X), Kazakhstan ($X) and Kyrgyzstan ($X) appeared to be the countries with the highest levels of imports in 2021, together accounting for X% of total imports.

Among the main importing countries, Uzbekistan, with a CAGR of +X%, saw the highest rates of growth with regard to the value of imports, over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

In 2021, the import price in Central Asia amounted to $X per ton, increasing by X% against the previous year. Over the period from 2012 to 2021, it increased at an average annual rate of +X%. The level of import peaked at $X per ton in 2015; however, from 2016 to 2021, import prices stood at a somewhat lower figure.

Prices varied noticeably by the country of destination: the country with the highest price was Uzbekistan ($X per ton), while Tajikistan ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by Uzbekistan (+X%), while the other leaders experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :